Explore

Cell Signaling and Intracellular Trafficking in Cancer Biology

Cell Signaling and Intracellular Trafficking in Cancer Biology: Interplay, Targeting and Therapy 2019

Turin, Italy
21 - 24 October 2019
The conference ended on 24 October 2019

Important Dates

Abstract Submission Deadline
21st August 2019
Early Bird Deadline
21st August 2019

About Cell Signaling and Intracellular Trafficking in Cancer Biology

The interplay between cell signaling and intracellular trafficking is implicated in fundamental cellular processes including cell growth and motility, whereas aberrant membrane trafficking events and signaling pathways are frequently associated with malignant transformation and cancer. The aim of this scientific conference is to merge advanced topics in cancer cell signaling together with emerging research themes in lipid metabolism, intracellular organelles and membrane trafficking. We will discuss oncogenic pathways and signaling networks as therapeutic targets and highlight their regulation by endomembranes and trafficking events.

Topics

Cancer, Networks, Targeted therapies, Signalling, Signaling, Membrane trafficking, Resistance

Call for Papers

Abstract Submission Guidelines

The maximum number of words allowed in your abstract body is 230. 

Please type your abstract straight into the online submission form, or alternatively paste the text from a word-processed document. 

The ‘Full title’ should be presented sentence case (not in Title Case or BLOCK CAPITALS), that is only the first letter of the title or appropriate terms such as abbreviations or proper nouns should be upper case. 

Has my abstract been accepted? Approximately 2 weeks after the abstract submission deadline has passed, you will receive an email informing you whether your abstract has been accepted/rejected as an oral communication or poster. All abstracts will be available to view online at the meeting.

Keep Up to Date with PaperCrowd

Sign up and follow your favorite conferences.

We are no longer accepting conference submissions on PaperCrowd. We apologise for any inconvenience.